Table 1.

All analyzed blood samples were within normal limits for mice for all cell populations. Further, no significant difference was observed in any of the cell populations across any time point between CFP+, wildtype and chimera mice. n = 4–7 for each cohort.

			2 weeks			4 weeks			8 weeks			16 weeks
Parameter and normal range			Cyan	Wildtype	Chimera	Cyan	Wildtype	Chimera	Cyan	Wildtype	Chimera	Cyan	Wildtype	Chimera
Leukocytes
WRB	1.8–10.7	(K/μL)	8.16 ± 3.21	9.73 ± 2.46	8.42 ± 1.16	9.59 ± 1.23	7.94 ± 1.15	9.46 ± 0.78	9.94 ± 0.95	9.56 ± 0.50	9.84 ± 0.45	9.97 ± 0.57	10.5 ± 0.76	9.80 ± 0.72
Neutrophil	0.1–2.4	(K/μL)	1.42 ± 1.10	1.70 ± 0.85	1.41 ± 0.33	1.08 ± 0.21	1.27 ± 0.14	1.67 ± 0.06	1.88 ± 0.28	1.81 ± 0.41	1.58 ± 0.26	1.40 ± 0.23	1.55 ± 0.61	1.62 ± 0.40
Leukocyte	0.9–9.3	(K/μL)	6.04 ± 1.71	7.37 ± 1.31	6.46 ± 1.03	7.92 ± 0.88	6.29 ± 1.18	7.16 ± 0.72	7.44 ± 0.62	7.37 ± 0.80	7.81 ± 0.32	8.02 ± 0.30	8.47 ± 0.67	7.64 ± 0.30
Monocyte	0.0–0.4	(K/μL)	0.38 ± 0.18	0.35 ± 0.14	0.36 ± 0.03	0.29 ± 0.03	0.18 ± 0.08	0.40 ± 0.09	0.34 ± 0.05	0.23 ± 0.05	0.32 ± 0.06	0.30 ± 0.14	0.25 ± 0.08	0.35 ± 0.06
Eosinophil	0.0–0.2	(K/μL)	0.22 ± 0.20	0.21 ± 0.11	0.14 ± 0.07	0.23 ± 0.14	0.13 ± 0.05	0.17 ± 0.06	0.21 ± 0.10	0.10 ± 0.03	0.08 ± 0.01	0.18 ± 0.16	0.14 ± 0.06	0.11 ± 0.04
Basophil	0.0–0.2	(K/μL)	0.1 ± 0.09	0.09 ± 0.07	0.06 ± 0.03	0.08 ± 0.03	0.07 ± 0.03	0.05 ± 0.02	0.07 ± 0.03	0.05 ± 0.02	0.06 ± 0.02	0.06 ± 0.06	0.07 ± 0.03	0.08 ± 0.03
Erythrocytes
RBC	6.36–9.42	(m/μL)	6.79 ± 1.94	6.53 ± 0.88	6.39 ± 0.12	7.69 ± 0.13	6.83 ± 1.39	6.86 ± 0.25	8.33 ± 1.26	8.15 ± 0.72	7.63 ± 0.43	8.30 ± 0.98	7.46 ± 0.67	8.92 ± 0.50
Hematocrit	35.1–45.4	(%)	40.8 ± 4.33	38.9 ± 0.91	36.8 ± 2.48	34.2 ± 0.87	40.8 ± 0.93	36.0 ± 0.98	38.4 ± 2.66	41.0 ± 2.33	39.0 ± 0.71	38.6 ± 2.43	39.8 ± 0.69	43.8 ± 1.06
Thrombocytes
Platelet	592–2972	(K/μL)	632 ± 29.1	715 ± 134	623 ± 143	620 ± 18.4	620 ± 36.0	615 ± 34.3	587 ± 27.7	618 ± 76.7	620 ± 47.2	597 ± 39.7	594 ± 14.6	625 ± 55.5